ITMI20041855A1 - Composizioni farmaceutiche di alfa-diidroergocriptina per uso transdermico e-o transmucoso. - Google Patents

Composizioni farmaceutiche di alfa-diidroergocriptina per uso transdermico e-o transmucoso.

Info

Publication number
ITMI20041855A1
ITMI20041855A1 IT001855A ITMI20041855A ITMI20041855A1 IT MI20041855 A1 ITMI20041855 A1 IT MI20041855A1 IT 001855 A IT001855 A IT 001855A IT MI20041855 A ITMI20041855 A IT MI20041855A IT MI20041855 A1 ITMI20041855 A1 IT MI20041855A1
Authority
IT
Italy
Prior art keywords
transmucous
dihydroergocriptine
alfa
transdermal
pharmaceutical compositions
Prior art date
Application number
IT001855A
Other languages
English (en)
Inventor
Susi Burgalassi
Patrizia Chetoni
Federico Mailland
Daniela Monti
Luigi Saccomani
Marco Fabrizio Saettone
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa filed Critical Polichem Sa
Priority to IT001855A priority Critical patent/ITMI20041855A1/it
Publication of ITMI20041855A1 publication Critical patent/ITMI20041855A1/it
Priority to PCT/EP2005/053630 priority patent/WO2006034902A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
IT001855A 2004-09-29 2004-09-29 Composizioni farmaceutiche di alfa-diidroergocriptina per uso transdermico e-o transmucoso. ITMI20041855A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT001855A ITMI20041855A1 (it) 2004-09-29 2004-09-29 Composizioni farmaceutiche di alfa-diidroergocriptina per uso transdermico e-o transmucoso.
PCT/EP2005/053630 WO2006034902A1 (en) 2004-09-29 2005-07-26 Pharmaceutical compositions of alpha-dihydroergocryptine for transdermal and/or transmucosal use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001855A ITMI20041855A1 (it) 2004-09-29 2004-09-29 Composizioni farmaceutiche di alfa-diidroergocriptina per uso transdermico e-o transmucoso.

Publications (1)

Publication Number Publication Date
ITMI20041855A1 true ITMI20041855A1 (it) 2004-12-29

Family

ID=34979884

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001855A ITMI20041855A1 (it) 2004-09-29 2004-09-29 Composizioni farmaceutiche di alfa-diidroergocriptina per uso transdermico e-o transmucoso.

Country Status (2)

Country Link
IT (1) ITMI20041855A1 (it)
WO (1) WO2006034902A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2726196A1 (en) * 2008-04-24 2009-10-29 Sunnywipes Pty Ltd Disinfecting formulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU17780A (en) * 1980-01-23 1984-10-31 Lek Tovarna Farmacevtskih Process for preparing a stable solution of ergot alkaloid derivatives
IT1200603B (it) * 1985-04-04 1989-01-27 Poli Ind Chimica Spa Composizione farmaceutiche ad attivita dopaminergica
YU45500B (en) * 1988-05-09 1992-05-28 Lek Tovarna Farmacevtskih Process for preparing new long lasting eye grease which contains ergot alcaloids
IT1245369B (it) * 1991-03-28 1994-09-20 Poli Ind Chimica Spa Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice
IT1305303B1 (it) * 1999-03-10 2001-05-04 Farmigea Spa Uso dell'olio essenziale di niaouli come promotore per la permeazionetransdermica.
WO2000054773A1 (en) * 1999-03-12 2000-09-21 Nitromed, Inc. Dopamine agonists in combination with nitric oxide donors, compositions and methods of use

Also Published As

Publication number Publication date
WO2006034902A1 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
BRPI0511900A (pt) composições farmacêuticas
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
BRPI0609802A2 (pt) composto, composição farmacêutica e uso de um composto
RU2398586C3 (ru) Фармацевтическая композиция
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
CL2007002017A1 (es) Compuestos derivados de [4,5']-bipirimidinil-6,4'-diamina; composicion farmaceutica; y uso como inhibidor de la actividad de cinasa en cancer de vejiga, cancer cervical y mieloma multiple.
DK3072507T3 (da) Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi
HUP0303313D0 (en) Transdermal pharmaceutical compositions
NO20075628L (no) Farmasøytiske formuleringer
DK1725218T3 (da) Farmaceutisk sammensætning omfattende pimobendan
DK2033629T3 (da) Fast farmaceutisk sammensætning omfattende valsartan
BRPI0614730A2 (pt) composto, composição farmacêutica, e, uso de um composto
CL2004000449A1 (es) Compuestos derivados de imidazol-4-il-etinil-piridina, para tratar trastornos mediados por el receptor mglur5; procedimiento de preparacion de los compuestos; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en
DK1587478T3 (da) Farmaceutisk sammensætning
BRPI0611748A2 (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
BRPI0813587A2 (pt) Composto, uso do mesmo, e, composição farmacêutica
CL2004001678A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica; y uso de los compuestos como agentes bacterianos.
BRPI0615630A2 (pt) composição farmacêutica, e, uso de sertindol
ITMI20041763A1 (it) Nuove formulazioni iniettabili contenenti progesterone
MA28603B1 (fr) Composition pharmaceutique antimycobacterienne
SM200400022A (it) Composti farmaceutici transdermici
DK1784174T3 (da) Famaceutisk sammensætning omfattende gabapentin